Pharmaceuticals News and Research

RSS

Drug companies spend about 37% of their overall R&D budgets on clinical affairs

Over the last decade, clinical services industry growth has exploded. Today, study sponsors dedicate significant portions of their budgets to CROs, SMOs and patient recruiters to access the expertise needed to speed trials to safe and successful fruition.

23 Jun 2004

FDA to be sued by Mylan Laboratories

Mylan Laboratories Inc. today announced that it is filing suit against the Food and Drug Administration (FDA) in the U.S. District Court for the District of Columbia

23 Jun 2004

European Commission has approved the use of Herceptin® (trastuzumab) in combination with Taxotere®

The approval is based on study results which showed that for women with HER2-positive breast cancer, the combination of Herceptin and Taxotere significantly improved median life expectancy by more than one-third (31 months with Herceptin plus Taxotere vs. 22 months for Taxotere alone).

23 Jun 2004

1 million deaths from malaria per year

Malaria remains a global health problem of staggering dimensions and despite many efforts to fight the disease; the situation today is worsening with more than 1 million deaths per year.

22 Jun 2004

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells could become a potent way to tackle the disease, a leading Cancer Research UK scientist reveals at a conference in Glasgow today (Tuesday).

22 Jun 2004

Pharmaxis completes interim analysis on Bronchitol study

Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.

21 Jun 2004

DEA Controlled Substance Act Registration Database now on-line

The Drug Enforcement Administration, as part of its efforts to control the abuse and misuse of controlled substances and chemicals used in producing some over-the-counter drugs, maintains databases of individuals registered to handle these substances.

21 Jun 2004

WHO removes two antiretroviral products from the WHO List of prequalified products

The World Health Organization (WHO) removed two antiretroviral products from the WHO List of prequalified products

20 Jun 2004

Drug for multiple sclerosis prevented disease development when tested on animal models

Scientists from the Neurological Sciences Institute at Oregon Health & Science University have shown that an investigative drug for multiple sclerosis and related diseases prevented disease development when tested on animal models.

20 Jun 2004

Regular use of beta-agonist drugs for asthma could be endangering their patients

Physicians who prescribe the regular use of beta-agonist drugs for asthma could be endangering their patients, two new studies by researchers at Cornell and Stanford universities find.

17 Jun 2004

Intrinsa patch increases sexual desire in menopausal women

Data released from a second, large-scale safety and efficacy study showed treatment with Intrinsa, an investigational female testosterone patch, significantly increased satisfying sexual activity and sexual desire in menopausal women

17 Jun 2004

Research on the potential oral delivery of a current intravenous cancer drug using polymeric nano-delivery systems technology

Labopharm Inc. today announced that it has entered into an agreement with Debiopharm S.A. under which Debiopharm has engaged Labopharm to conduct research on the potential oral delivery of a current intravenous cancer drug using Labopharm’s proprietary polymeric nano-delivery systems technology (also referred to as micelles technology).

16 Jun 2004

Pulsed dye laser therapy not effective in treating acne

Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.

16 Jun 2004

Benefits of current therapeutic options for pancreatic cancer are eclipsed by their toxicity and inconvenience

Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues, finds that the benefits of current therapeutic options for pancreatic cancer are eclipsed by their toxicity and inconvenience, especially in advanced stages of the disease.

15 Jun 2004

New software helps understanding of protein-protein docking

These algorithms enable more efficient life science research by helping scientists to understand the action of therapeutically interesting proteins by predicting the manner in which two proteins interact at the atomic level.

15 Jun 2004

Outsourcing the way to control spiraling R&D budgets in drug industry

Companies developing new drugs for the global market must deal with the rising costs of the R&D process – and outsourcing may well be the best route. That's the verdict of Dr Faiz Kermani, a specialist in outsourcing and research development for the pharmaceutical industry.

14 Jun 2004

Cannabis extract drug may help patients with rheumatoid arthritis

The multi centre double blind, randomised, parallel group study in 58 patients assessed the efficacy, safety and tolerability of Sativex®, a whole plant medicinal cannabis extract, compared with placebo for the treatment of pain caused by Rheumatoid Arthritis. Study medication was administered by means of a spray into the mouth as an evening dose only and measures were assessed the following day.

11 Jun 2004

Sirolimus-based therapy following early cyclosporine withdrawal improves transplanted kidney structure and function

Kidney histology and function three years after transplantation are better in kidney-transplant patients who remain on sirolimus-based therapy following early withdrawal of cyclosporine than in patients who continue on this calcineurin inhibitor, according to a new study published in the American Journal of Transplantation.

11 Jun 2004

Chemical agents extracted from Caribbean sea squirt may help find cancer treatments for certain deadly tumours

European Union funding is helping to find cancer treatments for certain deadly tumours using small marine animals. European researchers are using chemical agents extracted from a type of Caribbean sea squirt, named Ecteinascidia turbinata, to treat some tumours.

11 Jun 2004

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Johns Hopkins Kimmel Cancer Center clinicians were among those at leading institutions that have completed a three-year international study showing that docetaxel, a drug made from yew tree needles, decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy.

11 Jun 2004

Pharmaceuticals News and Research

Drug companies spend about 37% of their overall R&D budgets on clinical affairs

FDA to be sued by Mylan Laboratories

European Commission has approved the use of Herceptin® (trastuzumab) in combination with Taxotere®

1 million deaths from malaria per year

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Pharmaxis completes interim analysis on Bronchitol study

DEA Controlled Substance Act Registration Database now on-line

WHO removes two antiretroviral products from the WHO List of prequalified products

Drug for multiple sclerosis prevented disease development when tested on animal models

Regular use of beta-agonist drugs for asthma could be endangering their patients

Intrinsa patch increases sexual desire in menopausal women

Research on the potential oral delivery of a current intravenous cancer drug using polymeric nano-delivery systems technology

Pulsed dye laser therapy not effective in treating acne

Benefits of current therapeutic options for pancreatic cancer are eclipsed by their toxicity and inconvenience

New software helps understanding of protein-protein docking

Outsourcing the way to control spiraling R&D budgets in drug industry

Cannabis extract drug may help patients with rheumatoid arthritis

Sirolimus-based therapy following early cyclosporine withdrawal improves transplanted kidney structure and function

Chemical agents extracted from Caribbean sea squirt may help find cancer treatments for certain deadly tumours

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News